P-369 Optimizing the Alcyone Trial: Efficacy of Daratumumab And Bortezomib Maintenance in Non-Transplant Eligible Newly Diagnosed Multiple Myeloma Patients Post Dara-Vmp Induction, 1 Year Analysis
Luis Esteban Tamariz-Amador, Borja Puertas, Miguel‐Teodoro Hernández, Alfonso Garcia et autres